Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer
ConclusionThe results suggest the need for monitoring non-hematological reactions during the docetaxel phase of FAC-D treatment. The factors related to more severe reactions depend on the chemotherapy protocol used.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Brazil Health | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Docetaxel | Endocrinology | Genetics | Hematology | Men | Menopause | Pain | Taxotere | Women